Sustainability & Climate

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

Celltrion's SteQeyma autoinjector gets a CHMP nod, enhancing patient care and intensifying competition in Europe's crowded biosimilar market.

New Measure A funds will provide emergency rental aid to thousands of at-risk households, marking a major step in the county's new housing strategy.

With a pivotal FDA date set for June 2026, Achieve Life Sciences heads to the J.P. Morgan conference to discuss its promising anti-smoking drug.

The insurer's routine preferred stock dividend declaration masks a deeper story of record profits, strategic execution, and strong analyst confidence.

Early Phase 1a data for Kalaris's new nAMD drug shows significant vision improvement and potential for extended durability, aiming to reduce patient burden.

Edmond CEO Jill Castilla testified before Congress, urging a new approach to deposit insurance that protects small businesses without crippling community banks.

Gabb Wireless just hired four middle-schoolers as VPs. Is it a marketing stunt or a revolutionary step for child digital wellness in a screen-obsessed world?

Businesses are shifting from cheap trinkets to useful giveaways. Discover how practical promotional items build lasting loyalty and deliver powerful ROI.

Incyte's Minjuvi, a first-of-its-kind immunotherapy, gains EC approval for follicular lymphoma, offering patients a powerful new chemo-free option.

The nation's oldest family-owned Mexican food producer is building a massive new facility in Jefferson, promising jobs and fueling its national growth.

A key trial update de-risks Tenax Therapeutics' pivotal study for a novel heart failure therapy, boosting confidence in its path to market.

In under two years, a premium cookie mix startup has landed on Target and Costco shelves. Here's how My Better Batch is rewriting the recipe for success.

Amid a lagging stock price, Western Uranium & Vanadium is launching a significant share buyback, signaling deep confidence in its undervalued assets.

CERo Therapeutics reports early safety success and dose escalation in its Phase 1 AML trial for CER-1236, a novel cell therapy for high-risk patients.

New data reveals a novel wound gel is successfully treating conditions previously deemed unhealable, offering hope against chronic wounds and antibiotic resistance.

As Simply Good Foods preps its Q1 report, investors weigh Quest's strong growth against the ongoing struggles of its Atkins brand and market pressures.

Armed with breakthrough data on an AI-designed therapy that penetrates the brain, Rakovina Therapeutics heads to JPM Week to court major partners.

The famed travel host joins the Day1 program to discuss how global exploration can be a profound spiritual practice, fostering hope in a divided world.

A lawsuit alleges gross negligence by Holiday Inn and Airgas after a toxic ammonia leak from a tanker left hotel guests with horrific, life-altering injuries.